Teladoc Inc

Levi & Korsinsky has notified investors of a pending securities investigation into Teladoc Health following a second-quarter 2026 revenue shortfall that erased roughly a quarter of the company's market value. Teladoc reported consolidated revenue of $606.9 million, below consensus estimates that ranged from $615 million to $628 million, while its BetterHelp segment revenue fell 12% year-over-year to $212.6 million. The company also reduced its full-year 2026 revenue outlook to between $2.36 billion and $2.45 billion and slashed BetterHelp segment revenue growth expectations to a decline of 19% to 12.7%. Shares dropped around 29% intraday on the news. The investigation concerns potentially materially false or misleading statements about the company's forward revenue outlook, and shareholders who purchased TDOC and suffered losses may request a no-cost review of their recovery options.

Microsoft shares surged 15.5 percent in midday trading on July 30, driving a broad tech rally after the company reported strong quarterly results. The Nasdaq Composite rose 2.61 percent to 25,0810, the S&P 500 gained 1.29 percent to 7,422, and the Dow Jones Industrial Average added 0.81 percent to 52,010. Technology stocks overall climbed 4.31 percent, while real estate and healthcare sectors lagged. Sprouts Farmers Market also jumped on an earnings beat, Micron Technology rallied alongside gains in Samsung Electronics, but Teladoc Health plunged over 26.8 percent after cutting its guidance. The rally came despite data showing U.S. GDP growth slowed to 1.5 percent in the second quarter, below expectations, amid persistent inflation and reduced government spending.

Teladoc Health reported a second-quarter 2026 adjusted loss of 21 cents per share, beating the Zacks Consensus Estimate of a loss of 24 cents but widening from a loss of 19 cents a year earlier. Operating revenues declined 4% year over year to $606.9 million, missing the consensus estimate by 1.3%, as strength in the Integrated Care segment and higher international revenues were offset by weakness in the BetterHelp segment. Integrated Care revenues rose 1% to $394.3 million with adjusted EBITDA up 14% to $65.2 million, while BetterHelp revenues fell 12% to $212.6 million and adjusted EBITDA plunged 96% to $0.47 million. Total visits dipped 2% to 4.1 million, and U.S. Integrated Care members declined 2% to 100.3 million. For the third quarter, Teladoc expects total revenues between $569 million and $609 million and adjusted EBITDA between $62 million and $74 million, while full-year revenue guidance was lowered to a range of $2.362 billion to $2.447 billion.

Meta Platforms tumbled more than 9% after posting quarterly earnings per share of $6.18, missing analysts' estimates by $1.04 per share, while Microsoft jumped 15% on revenue of $90.01 billion that topped expectations. MarketAxess surged 30% after Intercontinental Exchange agreed to buy the bond trading platform for $167 per share in a deal valued at more than $5 billion. Crocs dropped more than 10% despite beating fiscal second-quarter expectations and raising its forecast, as margins came in weaker than expected. Other notable movers included Quanta Services up nearly 15% on strong results, Fair Isaac plunging more than 16% on mixed results and a delayed direct license program, and Teladoc Health sinking 29% after missing revenue estimates and lowering guidance.

Several major companies saw sharp premarket moves following their latest earnings reports. Microsoft jumped 9% after quarterly revenue of $90.01 billion beat the $87.62 billion estimate, with Azure growth of 43% at constant currency exceeding expectations and Azure revenue surpassing $100 billion for the first time in the 2026 fiscal year. Meta Platforms tumbled nearly 9% after earnings per share of $6.18 missed estimates by $1.04 and its third-quarter revenue forecast of $61 billion to $64 billion came in light at the lower end. Teladoc Health plunged 18.5% on a revenue miss and lowered full-year guidance, while Norwegian Cruise Line fell 7% after cutting its full-year earnings forecast to $1.50 per share. Starbucks rose 6% on raised full-year outlook and same-store sales growth of 7.9%, and Fortinet soared 12% on strong billings and an upbeat third-quarter forecast. MarketAxess shares were halted on news of its acquisition by Intercontinental Exchange for $167 per share in a deal valued at more than $5 billion.

Microsoft shares surged 8% after the company delivered a strong fiscal fourth-quarter beat fueled by accelerating AI and cloud demand, while Meta Platforms fell 7% as surging expenses and a higher capital-expenditure outlook overshadowed solid growth. Microsoft reported revenue up 18% to $90 billion and adjusted earnings per share of $4.74, with Azure revenue growing 43% and Intelligent Cloud sales exceeding expectations; Azure surpassed $100 billion in annual revenue for the first time and Microsoft 365 Copilot reached more than 30 million paid seats. Meta’s second-quarter earnings per share missed estimates as operating expenses surged 55% on higher AI investment, legal costs, and restructuring charges, and the company raised the lower end of its fiscal 2026 expense outlook and increased capex guidance to $130 billion to $145 billion. Among other movers, Chipotle Mexican Grill gained 6% on stronger-than-expected comparable sales and an improved full-year outlook, Starbucks jumped 5% after its fourth consecutive quarter of positive comparable sales and upbeat guidance, Teladoc Health plunged 17% on a revenue miss and weak guidance, and Qualcomm fell 5% as its fourth-quarter adjusted earnings-per-share guidance came in below expectations.

Shares of DoorDash, Bumble, and Teladoc fell sharply in afternoon trading after President Trump declared the Iran ceasefire over and vowed further strikes, driving oil prices and bond yields higher in a risk-off rotation. DoorDash dropped 6.2%, Bumble fell 5.4%, and Teladoc declined 4% as rising yields pressured long-duration growth stocks whose valuations depend heavily on future cash flows. The spike in crude and inflation fears pushed government bond yields up, increasing the discount rate applied to distant earnings and repricing high-multiple shares lower. Consumer internet companies are also cyclically exposed, with advertising budgets and online discretionary purchases softening when consumers face higher energy costs and corporate caution rises. DoorDash shares are now down 15.9% year-to-date, trading at $184.89, which is 34.4% below its 52-week high of $281.74 from October 2025.

Hims & Hers Health and Teladoc Health present contrasting investment cases in digital healthcare for 2026. Hims & Hers reported fiscal 2025 revenue of nearly $2.3 billion, a 59% jump, with net income of approximately $128.4 million and a net margin of roughly 5.5%, while Teladoc posted revenue of approximately $2.5 billion, a slight decline of nearly 1.5%, and a net loss of close to $200.3 million, though that loss narrowed from $1.0 billion the prior year. Hims & Hers serves nearly 2.6 million subscribers through its direct-to-consumer wellness platform and is scaling via a pending acquisition of Eucalyptus and a $400 million receivables facility with JPMorgan Chase, whereas Teladoc reaches over 100 million members globally and recently partnered with Walmart to integrate virtual care into retail platforms. Regulatory risks loom for Hims & Hers around compounded GLP-1s and a potential DOJ and HHS investigation, while Teladoc faces customer concentration with its top five clients historically accounting for nearly 19% of revenue and struggles with declining paying users in its BetterHelp segment. On valuation, Hims & Hers trades at a forward P/E of 78.9x and a P/S ratio of 3.5x, compared to Teladoc's forward P/E of 59.4x and P/S ratio of 0.7x. The analysis concludes that Hims & Hers is the preferred pick for its steady subscription-driven growth, while Teladoc may appeal to bargain-seeking investors betting on a turnaround.

StockStory highlights Brinker International as a value stock with solid fundamentals, while flagging Teladoc and Jack in the Box as stocks to avoid. Brinker International, trading at $177.68 per share with a forward P/E of 14.5x, has posted average same-store sales growth of 15.5% over the past two years and generates $5.73 billion in revenue, giving it scale and bargaining power. In contrast, Teladoc faces flat sales and a 9% annual decline in average revenue per user, and Jack in the Box is dealing with weak same-store sales and restaurant closures.